Defining the Cynomolgus Macaque (Macaca fascicularis) Animal Model for Aerosolized Venezuelan Equine Encephalitis: Importance of Challenge Dose and Viral Subtype
Viruses · 29.11.2023 · 15 (12) · 2351
DOI: 10.3390/v15122351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 29.11.2023. Verfasst von Crystal W Burke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. Hauptthemen laut MEDLINE: Encephalomyelitis, Venezuelan Equine, Viral Vaccines, Encephalitis Virus, Venezuelan Equine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Defense Threat Reduction Agency, Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) for Chemical and Biological Defense (CBD).
Abstract (Originalsprache)
Venezuelan equine encephalitis virus (VEEV) outbreaks occur sporadically. Additionally, VEEV has a history of development as a biothreat agent. Yet, no FDA-approved vaccine or therapeutic exists for VEEV disease. The sporadic outbreaks present a challenge for testing medical countermeasures (MCMs) in humans; therefore, well-defined animal models are needed for FDA Animal Rule licensure. The cynomolgus macaque (CM) model has been studied extensively at high challenge doses of the VEEV Trinidad donkey strain (>1.0 × 108 plaque-forming units [PFU]), doses that are too high to be a representative human dose. Based on viremia of two subtypes of VEEV, IC, and IAB, we found the CM infectious dose fifty (ID50) to be low, 12 PFU, and 6.7 PFU, respectively. Additionally, we characterized the pattern of three clinical parameters (viremia, temperature, and lymphopenia) across a range of doses to identify a challenge dose producing consistent signs of infection. Based on these studies, we propose a shift to using a lower challenge dose of 1.0 × 103 PFU in the aerosol CM model of VEEV disease. At this dose, NHPs had the highest viremia, demonstrated a fever response, and had a measurable reduction in complete lymphocyte counts—biomarkers that can demonstrate MCM efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
- Statistics Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
- Risk Management Office, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
ORCID-Profile: Crystal W Burke, Rebecca A Erwin-Cohen, Charles E White
Förderung
- Defense Threat Reduction Agency
- Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) for Chemical and Biological Defense (CBD)
Zitieren
APA
Burke, C. W., Gardner, C. L., Goodson, A. I., Piper, A. E., Erwin-Cohen, R. A., White, C. E., & Glass, P. J. (2023). Defining the Cynomolgus Macaque (Macaca fascicularis) Animal Model for Aerosolized Venezuelan Equine Encephalitis: Importance of Challenge Dose and Viral Subtype. Viruses, 15(12), 2351. https://doi.org/10.3390/v15122351
Vancouver
Burke CW, Gardner CL, Goodson AI, Piper AE, Erwin-Cohen RA, White CE, et al. Defining the Cynomolgus Macaque (Macaca fascicularis) Animal Model for Aerosolized Venezuelan Equine Encephalitis: Importance of Challenge Dose and Viral Subtype. Viruses. 2023;15(12):2351. doi:10.3390/v15122351
BibTeX
@article{Burke2023,
author = {Burke, Crystal W and Gardner, Christina L and Goodson, Aimee I and Piper, Ashley E and Erwin-Cohen, Rebecca A and White, Charles E and Glass, Pamela J},
title = {Defining the Cynomolgus Macaque (Macaca fascicularis) Animal Model for Aerosolized Venezuelan Equine Encephalitis: Importance of Challenge Dose and Viral Subtype},
journal = {Viruses},
year = {2023},
volume = {15},
number = {12},
pages = {2351},
doi = {10.3390/v15122351}
}
EUVIMED